OUTCOMES |
Type of outcome
|
Outcome
|
Timepoint(s) at which outcome measured
|
Primary Outcome |
Change in the proportion of HIV-exposed infants retained in HIV care and treatment at 12 months of age. |
Retrospective data on previous 12-month will be collected at baseline
Prospective data on proportion of HEI at 12-months after program will be collected at endline |
Secondary Outcome |
Change in the proportion of HEIs with regular attendance as defined by monthly returns up to 6 months of age from 10 weeks to 6 months |
Previous 6 months collected at baseline
Prospective 6 months collected at 6 months into study |
Secondary Outcome |
Change in the proportion of HEIs with regular attendance as defined by monthly returns up to 12 months of age from 10 weeks to 12 months |
Retropsective data on previous 12 months collected at baseline
Prospective data on 12-months after study collected at endline |
Secondary Outcome |
Change in the proportion of HIV-positive children initiated on ART |
Retrospective data on previous 12 months collected at baseline
Prospective data on 12-months of study period collected at endline. |
Secondary Outcome |
Change in the proportion of HIV-positive children retained in care |
Retrospective data on previous 12 months collected at baseline
Prospective data on 12-months of study period collected at endline. |
Secondary Outcome |
6. Change in the proportion of HIV-positive mothers retained in care |
Retrospective data on previous 12 months collected at baseline.
Prospective data on 12-months of study period collected at endline. |
Secondary Outcome |
Change in the proportion of HIV-Exposed infants initiated on TB Isoniazid (INH) prophylaxis |
Retrospective data on previous 12 months collected at baseline.
Prospective data on 12-months of study period collected at endline. |
Secondary Outcome |
Change in the proportion of HIV positive mothers testing for TB |
Retrospective data on previous 12 months collected at baseline.
Prospective data on 12-months of study period collected at endline. |
Secondary Outcome |
Change in the proportion of HIV positive mothers receiving TB prophylaxis |
Retrospective data on previous 12 months collected at baseline.
Prospective data on 12-months of study period collected at endline. |
Secondary Outcome |
Change in the proportion of HIV positive mothers on TB treatment |
Retrospective data on previous 12 months collected at baseline.
Prospective data on 12-months of study period collected at endline. |
Secondary Outcome |
Difference in perceived social support of HIV-positive mothers among those in the intervention arm vs those in the control arm |
Retrospective data on previous 12 months collected at baseline. Prospective data on 12-months of study period collected at endline. |
Secondary Outcome |
Difference in perceived stigma of HIV-positive mothers among those in the intervention arm vs those in the control arm |
Retrospective data on previous 12 months collected at baseline.
Prospective data on 12-months of study period collected at endline. |
Secondary Outcome |
Difference in knowledge of mothers on i) importance of retention and adherence ii) family planning among those in the intervention arm vs those in the control arm |
Retrospective data on previous 12 months collected at baseline. Prospective data on 12-months of study period collected at endline. |